Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai.
Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual ... for multiple oncology indications and chronic graft-versus-host-disease.
Our team of audiologists and tech experts tested the industry’s leading hearing aids to find the best models for severe hearing loss. Phonak Naída is our top pick ... hearing aid usage tracking, ...
They ensure that your family stays healthy even during the severe AQI outside ... and performance is adjusted accordingly to achieve the best results. It is particularly useful in homes with ...
Today there are more options than ever for managing migraine effectively. Find out what might work for you with this comprehensive guide to acute and preventive prescription drugs.